AU2003204221A1 - Dipyridoimidazolderivatives useful in treating central nervous system disorders - Google Patents

Dipyridoimidazolderivatives useful in treating central nervous system disorders

Info

Publication number
AU2003204221A1
AU2003204221A1 AU2003204221A AU2003204221A AU2003204221A1 AU 2003204221 A1 AU2003204221 A1 AU 2003204221A1 AU 2003204221 A AU2003204221 A AU 2003204221A AU 2003204221 A AU2003204221 A AU 2003204221A AU 2003204221 A1 AU2003204221 A1 AU 2003204221A1
Authority
AU
Australia
Prior art keywords
dipyridoimidazolderivatives
useful
nervous system
central nervous
system disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2003204221A
Other versions
AU2003204221B2 (en
Inventor
Bruce E. Maryanoff
David Mccomsey
James Mcnally
Samuel O. Nortey
Allen B. Reitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US1998/020802 external-priority patent/WO1999018105A1/en
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Priority to AU2003204221A priority Critical patent/AU2003204221B2/en
Priority claimed from AU2003204221A external-priority patent/AU2003204221B2/en
Publication of AU2003204221A1 publication Critical patent/AU2003204221A1/en
Application granted granted Critical
Publication of AU2003204221B2 publication Critical patent/AU2003204221B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2003204221A 1997-10-07 2003-05-15 Dipyridoimidazolderivatives useful in treating central nervous system disorders Ceased AU2003204221B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003204221A AU2003204221B2 (en) 1997-10-07 2003-05-15 Dipyridoimidazolderivatives useful in treating central nervous system disorders

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US60061248 1997-10-07
PCT/US1998/020802 WO1999018105A1 (en) 1997-10-07 1998-10-05 Dipyridoimidazolderivatives useful in treating central nervous system disorders
AU10664/99A AU1066499A (en) 1997-10-07 1998-10-05 Dipyridoimidazolderivatives useful in treating central nervous system disorders
AU2003204221A AU2003204221B2 (en) 1997-10-07 2003-05-15 Dipyridoimidazolderivatives useful in treating central nervous system disorders

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU10664/99A Division AU1066499A (en) 1997-10-07 1998-10-05 Dipyridoimidazolderivatives useful in treating central nervous system disorders

Publications (2)

Publication Number Publication Date
AU2003204221A1 true AU2003204221A1 (en) 2003-06-19
AU2003204221B2 AU2003204221B2 (en) 2006-07-27

Family

ID=39339719

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003204221A Ceased AU2003204221B2 (en) 1997-10-07 2003-05-15 Dipyridoimidazolderivatives useful in treating central nervous system disorders

Country Status (1)

Country Link
AU (1) AU2003204221B2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69329654T2 (en) * 1992-08-19 2001-03-15 Mcneilab Inc 3-OXO-PYRIDO [1,2-A] BENZIMIDAZOLE-4-CARBOXYL AND 4-OXO-AZEPINO [1,2-A] BENZIMIDAZOLE-5-CARBOXYL DERIVATIVES SUITABLE FOR THE TREATMENT OF CENTRAL SYSTEM DISEASES

Similar Documents

Publication Publication Date Title
PL324313A1 (en) 10-axcyloxy 10,11-dihydrobenz/b,f/azepin-5-carboxyamides useful in treating nervous system disorders
PL337888A1 (en) Imidazoprimidines and imidazopyridines for use in treating neurological disorders
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
AU3153295A (en) Methods for treating addictive disorders
AU9262598A (en) Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders
AU8769098A (en) System for treating patients with anxiety disorders
AU7383398A (en) Therapeutic glasses and method for using the same
ZA977945B (en) Hydrogenation process
HUP0003964A2 (en) Methods for treating thrombotic disorders
AU1620699A (en) Middle distillate selective hydrocracking process
GB2319796B (en) Formation treatment method using deformable particles
AU7600198A (en) Formation treatment method using deformable particles
HK1018272A1 (en) Substituted pyridylmethylpiperazine and piperidinederivatives, their preparation and their use for treating central nervous system (cns) disorders
AU6859096A (en) Substituted cyclohexylamines as central nervous system agents
EP1011330A4 (en) Central nervous system axon regeneration
AU1184399A (en) Therapeutic molecules
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
AU6242498A (en) Methods for treating central and peripheral nerve pain
PL332313A1 (en) Application of benzopyranoles in treatment of neurological disorders
PL332821A1 (en) Pyrazolydinones for treating potency disorders
AU2892995A (en) Authentication technique
GB2359316B (en) Formation treatment method using deformable particles
AU4239597A (en) Novel pharmacotherapeutic process and composition for central nervous system disorders
AU6300898A (en) Well treatment with particles
HUP9902802A3 (en) Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders